Top ▲
Target not currently curated in GtoImmuPdb
Target id: 2038
Nomenclature: ciliogenesis associated kinase 1
Abbreviated Name: ICK
Family: RCK family
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 632 | 6p12.1 | CILK1 | ciliogenesis associated kinase 1 | |
Mouse | - | 629 | 9 E1 | Cilk1 | ciliogenesis associated kinase 1 | |
Rat | - | 629 | 8q31 | Cilk1 | ciliogenesis associated kinase 1 |
Previous and Unofficial Names |
ICK | Ick | intestinal cell kinase | intestinal cell (MAK-like) kinase | Laryngeal cancer kinase 2 | LCK2 |
Database Links | |
Alphafold | Q9UPZ9 (Hs), Q9JKV2 (Mm), Q62726 (Rn) |
BRENDA | 2.7.11.22 |
ChEMBL Target | CHEMBL1163126 (Hs) |
Ensembl Gene | ENSG00000112144 (Hs), ENSMUSG00000009828 (Mm), ENSRNOG00000008691 (Rn) |
Entrez Gene | 22858 (Hs), 56542 (Mm), 84411 (Rn) |
Human Protein Atlas | ENSG00000112144 (Hs) |
KEGG Enzyme | 2.7.11.22 |
KEGG Gene | hsa:22858 (Hs), mmu:56542 (Mm), rno:84411 (Rn) |
OMIM | 612325 (Hs) |
Orphanet | ORPHA201496 (Hs) |
Pharos | Q9UPZ9 (Hs) |
RefSeq Nucleotide | NM_014920 (Hs), NM_001163780 (Mm), NM_138886 (Rn) |
RefSeq Protein | NP_055735 (Hs), NP_001157252 (Mm), NP_620241 (Rn) |
UniProtKB | Q9UPZ9 (Hs), Q9JKV2 (Mm), Q62726 (Rn) |
Wikipedia | CILK1 (Hs) |
Enzyme Reaction | ||||
|
DiscoveRx KINOMEscan® screen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 1-2 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: ICK | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
Clinically-Relevant Mutations and Pathophysiology | ||||||||||||
|
1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
2. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
RCK family: ciliogenesis associated kinase 1. Last modified on 12/11/2019. Accessed on 24/01/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetoimmunopharmacology.org/GRAC/ObjectDisplayForward?objectId=2038.